Twist Bioscience

Director, R&D (NGS/Genomics)

South San Francisco, California, United States

Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
BiotechnologyIndustries

Requirements

Candidates should possess a PhD with 6+ years of post-graduate experience or a Master’s degree with 10+ years in Molecular Biology, Biochemistry, Genetics, Genomics, Chemistry, or a closely related field, along with deep technical knowledge and a strong understanding of NGS/genomics principles.

Responsibilities

As the Director of R&D, the individual will oversee the research and development of new NGS/genomics products, drive continuous improvement of existing processes and products, manage a diverse team of scientists, provide technical leadership in wet and dry lab research, collaborate cross-functionally to define product pipelines, and translate early research into product deliverables, ensuring projects stay on track by managing timelines and removing blockers for the team.

Skills

NGS
Genomics
Molecular Biology
Biochemistry
Genetics
Chemistry
Wet Lab Research
Dry Lab Research
Product Development
Technical Leadership
Project Management

Twist Bioscience

Produces synthetic DNA for biotechnology applications

About Twist Bioscience

Twist Bioscience specializes in creating synthetic DNA for applications in biotechnology, pharmaceuticals, and research. Their proprietary platform allows for the quick and accurate production of DNA sequences, providing clients with products like genes, oligo pools, and variant libraries. The company stands out by offering high-quality DNA at competitive prices, making them a valuable partner for academic institutions and pharmaceutical companies. Twist Bioscience aims to support advancements in personalized medicine and biotechnology through their innovative DNA synthesis solutions.

Key Metrics

South San Francisco, CaliforniaHeadquarters
2013Year Founded
$236.5MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
1,001-5,000Employees

Benefits

Health Insurance
Dental Insurance
Vision Insurance
Disability Insurance
Life Insurance
401(k) Retirement Plan

Risks

Increased competition from Ginkgo Bioworks may impact Twist's market share.
Dependency on AI technologies could pose integration and operational challenges.
New CIO appointment may lead to transitional challenges in IT strategy and operations.

Differentiation

Twist Bioscience uses a unique silicon-based DNA synthesis platform for precision and scale.
They offer high-quality DNA sequences at competitive prices, attracting diverse clients.
Their proprietary platform provides instant feedback on DNA sequence synthesis feasibility.

Upsides

Growing demand for synthetic DNA in personalized medicine boosts Twist's market potential.
Collaboration with Absci leverages AI to accelerate antibody discovery and drug development.
Synthetic biology market projected to grow at 28.8% CAGR, benefiting Twist's growth.

Land your dream remote job 3x faster with AI